Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Getinge

210.70 SEK

+0.29 %

Less than 1K followers

GETI B

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
+0.29 %
-5.18 %
+0.81 %
+13.31 %
+16.06 %
+25.27 %
-15.92 %
+15.77 %
+2,560.92 %

Getinge is a global medical technology company that specializes in providing equipment and IT systems to the healthcare and life science industry. The company offers, among other things, solutions for operating theatres, intensive care units, sterilization centers and drug development. The company was founded in 1904 and has its headquarters in Gothenburg.

Read more
Market cap
57.39B SEK
Turnover
63.11M SEK
Revenue
34.76B
EBIT %
8.21 %
P/E
35.06
Dividend yield-%
2.18 %
Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
27.1
2026

Annual report '25

21.4
2026

General meeting '26

21.4
2026

Interim report Q1'26

All
Webcasts
Press releases
ShowingAll content types
Getinge, Audiocast, Q3'25
Webcast10/21/2025, 8:00 AM

Getinge, Audiocast, Q3'25

Getinge
Regulatory press release10/21/2025, 6:00 AM

Getinge Interim Report July-September 2025: High organic sales growth and stronger margins despite geopolitical headwinds

Getinge
Press release10/16/2025, 2:00 PM

Modular Finance IR Consensus: Getinge – Consensus estimates Q3 2025

Getinge

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release10/13/2025, 8:00 AM

Getinge's Advanta V12 receives CE Mark for major bridging indications

Getinge
Press release10/7/2025, 6:00 AM

Getinge invites fund managers, analysts, and media to Q3 Report 2025 conference call

Getinge
Press release8/4/2025, 7:00 AM

Getinge: EU CE-Mark Reinstated for Cardiosave Intra-Aortic Balloon Pump

Getinge
Getinge, Audiocast, Q2'25
Webcast7/18/2025, 8:00 AM

Getinge, Audiocast, Q2'25

Getinge
Regulatory press release7/18/2025, 6:00 AM

Getinge Interim Report April-June 2025: Continuing positive trend with stable organic sales growth in all business areas and regions

Getinge
Press release7/15/2025, 12:00 PM

Modular Finance IR Consensus: Getinge – Consensus estimates Q2 2025

Getinge
Press release7/4/2025, 6:00 AM

Getinge invites fund managers, analysts, and media to Q2 Report 2025 conference call

Getinge
Regulatory press release4/22/2025, 3:00 PM

Resolutions at Getinge's Annual General Meeting April 22, 2025

Getinge
Getinge, Audiocast with teleconference, Q1'25
Webcast4/22/2025, 11:00 AM

Getinge, Audiocast with teleconference, Q1'25

Getinge
Regulatory press release4/22/2025, 10:00 AM

Getinge Interim Report January-March 2025: Strong sales and improved earnings - continued focus on customer value and profitability going forward

Getinge
Press release4/16/2025, 1:00 PM

Modular Finance IR Consensus: Getinge – Consensus estimates Q1 2025

Getinge
Press release4/8/2025, 7:00 AM

Getinge invites fund managers, analysts, and media to Q1 Report 2025 conference call

Getinge
Regulatory press release3/27/2025, 1:30 PM

Getinge publishes Annual Report for 2024

Getinge
Regulatory press release3/13/2025, 8:00 AM

Getinge: NOTICE OF ANNUAL GENERAL MEETING IN GETINGE AB (PUBL)

Getinge
Regulatory press release3/11/2025, 8:00 AM

Getinge's Nomination Committee proposes Ulrika Dellby as new Board member

Getinge
Getinge, Audiocast with teleconference, Q4'24
Webcast1/28/2025, 9:00 AM

Getinge, Audiocast with teleconference, Q4'24

Getinge
Regulatory press release1/28/2025, 7:00 AM

Getinge Year End Report 2024: Strong order intake and increased sales contributed to sharp improvement in margins

Getinge
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.